Pharmafile Logo
Pharmafocus logo
Advanced Search
gsk_hq_logo

GSK receives positive opinion for triple-therapy inhaler

September 15, 2017
Medical Communications, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical

GSK, alongside its partner Innoviva, has announced that it has received a positive opinion from the EMA’s CHMP for its …

News
sandoz

Sandoz psoriasis biosimilar tops reference product Humira in latest Phase 3 data

September 15, 2017
Medical Communications, Research and Development AbbVie, Humira, Novartis, Sandoz, adalimumab, biosimilar, biosimilars, pharma, pharmaceutical

Sandoz, the biologics and generics division of Novartis, has unveiled new Phase 3 data confirming the efficacy and safety profile …

News

Recipharm and Kancera collaborate to manufacture clinical trial supply

September 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm, a leading contract development and manufacturing organisation (CDMO) and Kancera, a development company focused on cancer therapy, have signed …

News
Press release
astrazeneca_logo_building

AstraZeneca’s Forxiga displays potential in type 1 diabetes

September 14, 2017
Research and Development AstraZeneca, Forxiga, biotech, drugs, farxiga, pharma, pharmaceutical

Forxiga is AstraZeneca’s treatment for those living with type 2 diabetes but the results from a new trial have found …

News
data

GDPR and Human Data Samples: Being ‘somewhat prepared’ is not enough

September 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GDPR, biotech, data, drugs, pharma, pharmaceutical

Thomas Hirse, Partner, and Paetrick Sakowski, Associate, CMS, discuss what pharmaceutical companies need to be aware of ahead of the …

Feature
gsk_boronia_australia

FDA panel gives GSK’s Shingrix unanimous approval

September 14, 2017
Sales and Marketing GSK, Shingrix, biotech, drugs, pharma, pharmaceutical, shingles

The FDA’s advisory panel has given a strong signal that GSK’s Shingrix should not have too much difficulty getting full …

News

Novo’s Xultophy beats basal insulin in cutting cardiovascular risk

September 14, 2017
Research and Development Novo Nordisk, Xultophy, diabetes, pharma, pharmaceutical, type 2 diabetes

Novo Nordisk has unveiled new data on its diabetes treatment Xultophy (insulin degludec/liraglutide) which supports its efficacy in reducing risk …

News
martin_shkreli_2016

‘Pharma bro’ Shkreli heads to jail

September 14, 2017
Medical Communications Martin Shkreli, Shkreli, biotech, drugs, pharma, pharmaceutical

Martin Shkreli’s habit of being unable to stay out of the headlines continues, although this time with the repercussion that …

News
shutterstock_159488225

Amicus pulls plug on rare skin disease drug after Phase 3 failure

September 14, 2017
Research and Development Amicus, epidermolysis bullosa, pharma, pharmaceutical, trial failure

New Jersey-based biotech firm Amicus Therapeutics has been forced to terminate its development of its candidate for treating rare skin …

News
antibiotic_sensitvity_and_resistance

UK collaboration presents promising data in the fight against antibiotic resistance

September 13, 2017
Research and Development Auspherix, antibiotic resistance, domainex, pharma

The collaborative efforts of Domainex and Auspherix have made new progress in the development of a solution to the growing …

News
sanofi_regeneron

Sanofi/Regeneron new asthma data bolstered by potential indications

September 13, 2017
Research and Development Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and Regeneron’s Dupixent is predicted to grow to be one of the largest selling drugs in the industry but …

News

Novartis’ Cosentyx proves long-term efficacy in psoriasis skin clearance

September 13, 2017
Research and Development Cosentyx, Novartis, pharma, pharmaceutical, psoriasis

At the European Academy of Dermatology and Venereology Congress in Geneva, Switzerland, Novartis unveiled new Phase 3 data for Cosentyx …

News
23andme

23andMe raises $250m in financing, research points towards its future

September 13, 2017
Research and Development, Sales and Marketing 23andME, biotech, drugs, pharma, pharmaceutical

23andMe made two announcements on the same day that point towards the future of its business: it revealed it had …

News

Recipharm and CTC launch integrated first in human service

September 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm, biotech, drugs, pharma, pharmaceutical

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch …

News
Press release
virus-1812092_960_720

Newly adopted flu vaccine could save 1,700 lives

September 12, 2017
Research and Development, Sales and Marketing biotech, drugs, flu, fluad, pharma, pharmaceutical, seqirus

The Fluad flu vaccine, produced by Seqirus, was approved by the MHRA for use beginning in 2018 and further data …

News

J&J backs out of $1.1 billion hep C deal, wiping 22.2% from Achillion’s stock

September 12, 2017
Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, achillion, hepatitis C, pharma

Johnson & Johnson has announced that it is to back out of a $1.1 billion deal with Achillion Pharmaceuticals to …

News

Teva announces sale of Paragard for $1.1 billion

September 12, 2017
Manufacturing and Production, Sales and Marketing Paragard, Teva, biotech, drugs, pharma, pharmaceutical

Shortly after the news that Teva had finally sealed the deal on a new CEO, it also announced that it …

News

FDA accepts license application for Novartis’ rituximab biosimilar

September 12, 2017
Manufacturing and Production, Sales and Marketing Novartis, Rituxan, Sandoz, biosimilar, rituximab

Sandoz, Novartis’ generics and biosimilars division, has revealed that the FDA has accepted its Biologics License Application (BLA) for a …

News

Questions raised after two deaths in AbbVie arthritis study

September 12, 2017
Manufacturing and Production, Research and Development AbbVie, biotech, drugs, pharma, pharmaceutical, rheumatoid arthritis

AbbVie’s rheumatoid arthritis drug, upadacitinib, is the company’s big plan to manage the inevitable loss of sales from Humira, as …

News
new_brand_image_sept_2017

PrimeVigilance launches new brand and logo

September 12, 2017
Manufacturing and Production, Sales and Marketing pharmacovigilance, primevigilance

PrimeVigilance has launched its new visual identity together with a new website. Additionally, it has begun harmonising its appearance within …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026